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Abstract 
 
In this contribution, a novel optimisation strategy has been presented that combines the metabolic flux 
analysis and pathway identification with the thermodynamic analysis of cellular metabolic systems. First, an 
optimal metabolic flux distribution among elementary pathways is identified by LP optimisation subject to 
constraints on flux balance analysis, pathway analysis and negative Gibbs free energy change for pathways, 
for achieving the maximum yield of products. The Gibbs free energy change for pathways is calculated 
from the new transformed Gibbs free energy of formation of external metabolites and cofactors that are in 
stoichiometric balance in metabolic pathways. The consideration of thermodynamic constraints on 
pathways ensures the selection of feasible pathways. Thereafter, the Gibbs free energy change of pathways 
is minimised to predict the optimal reaction conditions that facilitate such pathways. Thus the optimisation 
approach derives the optimal pathway distribution and conditions for the best performance of cellular 
systems. The effectiveness of the methodology is demonstrated by a case study on the optimisation of 
pentose phosphate pathway (PPP) and the glycolysis cycle of the insilico Escherichia coli. 
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1. Introduction 
 
Metabolic pathways are complex networks of enzyme catalyzed reaction steps presented in terms of internal 
metabolites, external metabolites and cofactors (a glossary on the terminologies has been provided in 
Appendix A). Such pathways, also known as elementary pathways are central to cellular biochemical 
activities, which channel substrate metabolites into production of energy currency, building blocks for 
biosynthesis, energy reserves, eliminating waste products, and for recycling reducing equivalents1 . In this 
light, to quantify intracellular reaction steps and pathways and infer the objectives of cellular metabolic 
systems, rational modeling strategies need to be developed for altering or optimising cell properties. 
Optimisation of cellular properties can achieve physiological endpoints corresponding to the production of a 
desired external metabolite. Hence, optimal metabolic pathways responsible for the productivity of a 
desired metabolite can be predicted. A rational modeling approach, such as, based on thermodynamic 
analysis for cellular properties may also elucidate the spontaneity and existence of driving force for the 
occurrence of metabolic pathways responsible for a desired product. Thus, the selection of optimal 
metabolic pathways for the productivity of a desired cellular product based on thermodynamic analysis is 
driven by the relative degree of spontaneity or feasibility among competing pathways. Furthermore, 
representation of thermodynamic properties for metabolic pathways in terms of cellular reaction conditions 
attains the optimal conditions corresponding to the productivity of a desired metabolite. In this work, we 
have proposed an optimisation based methodology for the productivity and reaction conditions of metabolic 
pathways using thermodynamic analysis.  
 
In recent years, several theoretical approaches have been developed to assign metabolic priorities through 
engineered cells. An optimisation-based framework, called ObjFind, has been established to infer and test 
hypothesized metabolic pathways and objectives depending upon experimental results 2 . A representative 
 modeling framework for metabolic analysis is the flux balance analysis (FBA), which can be used to infer 
the objectives of cellular metabolism 5,4,3 . FBA is a constrained optimisation approach based on linear 
programming (LP), and provides a desired physiological endpoint, e.g., the maximum growth rate, and its 
corresponding flux distribution under some culture conditions. In FBA, individual reaction steps and their 
corresponding metabolic flux balances, rather than metabolic pathways, are considered. The application of 
FBA has been effectively dealt with metabolic flux analysis problems for various kinds of networks 8,7,6 . 
Mahadevan et al. 9  have extended FBA for analyzing the dynamic reprogramming of a metabolic network. 
This dynamic FBA can be used to understand the dynamic behaviour of metabolic networks, and 
additionally, provide strategies for the design of a network with a desired objective for metabolic 
engineering. However, some critical issues about FBA remain unresolved10 , such as the uniqueness of flux 
distribution and its practical application. Firstly, the implementation of LP in FBA frequently leads to 
multiple (or alternate) optima depending on initial starting point. Thus for a same set of enzymes, different 
metabolic fluxes (that may belong to different pathways) are selected depending on an initial guess on 
metabolic fluxes. In practice, a set of enzymes is selectively responsible for a pathway or a set of pathways 
and an alteration of which disrupts such pathways to occur11 . In addition, it is difficult to apply FBA 
directly to predict the metabolic genotype-phenotype relation (e.g. gene to cellular expression) from a 
reaction-based perspective12 . Hence, FBA, without consideration of pathways, does not capture the genetic 
or enzymatic manipulation of cellular activities. Pathway analysis, on the other hand, is aimed at genetic / 
enzymatic manipulation of cells, which enables any steady-state metabolic network to be expressed as a 
collection of elementary pathways. Each elementary pathway is stoichiometrically feasible for a minimum 
set of enzymes 13 , and the activity of which can be controlled by inhibition or activation of its responsible 
enzymes. All these elementary pathways should be regarded as the true functional units of metabolic 
systems consisting of a series of irreversible reaction steps. Thus, a cell can be regulated by selective control 
of activities of elementary pathways to enhance the yield and rate of a metabolic production. Hence, we 
combine pathway analysis with FBA to integrate metabolic engineering to genetic technology for the 
 synthesis of novel products or redirecting metabolite fluxes towards a desired product. This also eliminates 
the existence of infeasible flux distribution caused by FBA uncertainty. 
 
Optimal metabolic fluxes based on mass balance thus obtained by combining pathway and flux balance 
analyses does not ensure feasibility of pathways. Hence, thermodynamic analysis can be instrumental to the 
selection of feasible pathways and identifying optimal cellular environment for metabolic systems. 
Thermodynamic insights into metabolic reaction networks or pathways are useful in estimating the key 
parameters in biotechnological cultures and thus to address reaction viability of bioprocesses 14 . In 
thermodynamic terms, the difference in Gibbs free energy sets the driving force for any system undergoing 
changes. For any phenomenon occurring spontaneously, its Gibbs free energy change ought to be negative. 
This is the basis for assessing the thermodynamic feasibility of a pathway in metabolic systems. Moreover, 
a pathway for which the free energy change is large and negative has an equilibrium that favors the side of 
products. Recently, Gibbs free energy changes for individual reaction steps in a metabolic pathway have 
been presented by Nolan et al. 1  in order to consider negative constraint on Gibbs free energy change for 
individual metabolic pathways in pathway analysis. In their study, the Gibbs free energies of formation of 
metabolic species are estimated using group contribution theory 15 . They have applied directionality 
criterion for net mss flux in the form of negative Gibbs free energy change to a pathway, as opposed to a 
reaction step. In many cases, cellular biochemistry, through multi-functional enzyme action, substrate 
channeling, or other mechanisms, couples an energetically unfavorable metabolic reaction to an 
energetically favorable one. In these cases, the negative Gibbs free energy change criterion applied to 
individual reactions would incorrectly predict opposing flux directions for consecutive reactions. Nolan et 
al. 1  presented an example of glycolysis which includes at least three reaction steps with unfavorable Gibbs 
free energy changes in the established direction from glucose to lactate16 . 
 
In this paper, we have introduced the new transformed Gibbs free energies of formation17  in terms of pH 
 and ionic strength, which are more suitable for biochemical reaction systems, for external metabolites and 
cofactors that are stoichiometrcally balanced in individual elementary pathways. Hence, in our work, Gibbs 
free energy changes have been directly presented for elementary pathways in a metabolic system as opposed 
to the work by Nolan et al. 1 , who considered thermodynamic descriptors for reaction steps to predict that 
for pathways. Moreover, Gibbs free energy changes of pathways have been minimised to attain the optimal 
pH and ionic strength conditions to facilitate such pathways. 
 
The paper is structured as follows. The methodology18  for the elucidation and optimisation of metabolic 
systems has been detailed in the first part. In the second part, a case study on the metabolism network of 
pentose phosphate pathways (PPP) and glycolysis cycle of in silico Escherichia coli has been established to 
demonstrate the effectiveness of this methodology. 
 
2. Methodology 
 
2.1 Thermodynamic analysis of metabolic reaction network 
 
Thermodynamic feasibility and optimisation of metabolic pathways based on Gibbs free energy changes is 
presented to formulate the optimisation problem for metabolic productivity and optimal reaction conditions. 
Generally speaking, there are two kinds of reaction equations, chemical equations which balance elements 
and charge, and biochemical equations written in terms of biochemical reactants at a specified pH 17 . In 
biochemical equations, hydrogen numbers are assumed fixed at a constant pH. The conventional 
thermodynamic properties thus can not represent biochemical systems precisely. Therefore, it is necessary 
to define the new transformed thermodynamic properties, like Gibbs free energy of formation, for 
biochemical reactants17 . Metabolic pathways can be expressed by biochemical equations. Hence, the new 
transformed Gibbs free energies of formation should be computed for the metabolites in a system. The 
 calculation of the standard formation Gibbs free energy of biochemical reactants as a function of pH and an 
ionic strength I is illustrated in Fig. 1.  
 
2.1.1 Gibbs free energy change for biochemical reaction 
 
The Gibbs free energy G  for a reaction system at a specific temperature (T) and pressure (P) is described 
in terms of species. 
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In Eq. (1), i  and in  are chemical potential and amount of specie i respectively and N is the number of 
species in the system.  
 
Eq. (1) provides the basis for deriving the data on the Standard formation Gibbs free energy ofG  of 
individual species. The superscript o and the word standard mean that the species are in aqueous solutions 
at 1 M (1 M = 1 lmol / ), while the interactions between ions and water are same as that in infinite dilution. 
Most of the ofG  values are taken from the NBS Tables of Chemical Thermodynamic Properties 19 . The 
o
fG  values for the ATP series are from 20 . 
 
The thermodynamic properties of a solution are affected by the interactions between the species in it. 
Therefore, the effect of ionic strength in a solution plays an important role in determining its 
thermodynamic state. Since the biochemical reactions mostly work at ionic strength which ranges from 0.1 
to 0.3 ( MI 3.01.0  ), the effects of the solution ionic strength have to be considered for the correction of 
the standard formation Gibbs free energy values. The standard formation Gibbs free energy of specie i at an 
ionic strength I can be calculated from the one at zero ionic strength using Eq. (2) 21 . 
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The formation Gibbs free energy is expressed in kJ/mol, iz  is the charge in specie i, and 2/12/16.1 molLB  .  
 
Biochemical reactions are enzyme-catalysed reactions at a specified pH. Many of the reactants are weak 
acids so that H  is also a reacting specie. When the concentration of a reacting specie is specified at an 
equilibrium, the thermodynamic properties of the solution depend on its specific concentration, as well as 
on the temperature and pressure. Thus, a new standard formation Gibbs free energy for species in a 
biochemical reaction is introduced as a function of hydrogen ion concentration (Eq. (3)).  
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In Eq. (3), )(HNi  is the number of hydrogen atoms in species i, and )/]log([ ocHpH   
 
In biochemical reactions, the reactants consist of species in equilibrium. Once we have calculated the 
standard formation Gibbs free energy oifG ,  at a pH for all the species of a reactant, the next step is to 
combine the oifG ,  values of these species as an integrated property for the reactant. The standard 
formation Gibbs free energy fG  of reactants at a specific pH is given by Eq. (4). Since all the external 
metabolites and cofactors in metabolism networks are expressed as biochemical reactants, thus, their 
corresponding formation Gibbs free energy EMefG  ,  should also calculated by Eq. (4).  
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In Eq. (4) isoN  is the number of species of the reactant, and oifG ,  is the standard formation Gibbs free 
energy of species of a reactant, )(reactG f .  
  
From Eqs. (2), (3) and (4), the standard formation Gibbs free energies of the external metabolites and 
cofactors, EMefG  , , in a metabolic pathway can be evaluated at a given pH and ionic strength. In the 
following section, an illustration on the calculation of the standard formation Gibbs free energy of 
metabolites is presented. 
 
2.1.2  An example for calculation 
 
An example is presented herein to elucidate the procedure of formation Gibbs free energy calculation of 
biochemical reactants. Reactant ATP in biochemical reactions refers to an equilibrium mixture of 4ATP , 
3HATP  and 22 ATPH  at a specified pH. The standard formation Gibbs free energy for 4ATP , 3HATP  
and 22 ATPH  at 25℃, 1 bar, and zero ionic strength ( 0I ), as well as their ionic charges and hydrogen 
atom numbers are shown in Table 1.  
 
Firstly, the formation Gibbs free energy of species 4ATP , 3HATP  and 22 ATPH  at  28.0I  are 
calculated using Eq. (2). 
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Next, the formation Gibbs free energy of species at a pH=6.8 are calculated by Eq. (3). 
}303.2)(){(444 ,, pHRTHGHNGG
o
fATP
o
ATPf
o
ATPf    
24.2111}8.6298008314.0303.284.0{1287.2586  molkJ /  
}303.2)(){(333 , pHRTHGHNGG
o
fHATP
o
HATPf
o
HATP    
13.2109}8.6298008314.0303.284.0{1340.2624  molkJ /  
}303.2)(){(2
2
2
2
2
2 ,,
pHRTHGHNGG foATPH
o
ATPHf
o
ATPHf    
02.2092}8.6298008314.0303.284.0{1493.2646  molkJ /  
 
Reactant ATP is a mixture of the three species: 4ATP , 3HATP and 22 ATPH . Thus, the number of species for 
ATP is 3 ( 3isoN ). The formation Gibbs free energy of reactant ATP is calculated using Eq. (4).  
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2.2  Flux balance analysis and pathway analysis  
 
Flux balance analysis (FBA) and pathway analysis are used for the systematic enumeration of elementary 
pathways and metabolic flux distributions among them. 
 
FBA is used to describe metabolic system models that include a complete list of reactions and metabolites 
(external as well as internal) and cofactors involved in each reaction step, in a quantitative manner. For FBA 
of metabolic systems, the information required is the stoichiometry of metabolic reaction steps, mass 
balance around internal metabolites under pseudo-steady state and the uptake of external metabolite 
sources 22 . The process of flux balance analysis is illustrated in Fig. 2.    
  
In FBA, a stoichiometry of metabolic reactions is presented by a NX   stoichiometric matrix ),( jiS , in 
terms of X number of internal metabolites IMi , in a total of N reactions Rj . Since it is reasonable to 
place the internal metabolites of a system into a steady state, a set of linear homogeneous equations based 
on mass balance can be derived. In matrix notation, the expression is presented in Eq. (5). V  is a 1N  
flux vector and represents the flux distribution of reactions in a metabolic system.  
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Pathway analysis is aimed at genetic / enzymatic manipulation of cells, which enables any steady-state 
metabolic network to be expressed as a collection of elementary pathways. Each elementary pathway is 
stoichiometrically feasible for a minimum set of enzymes, and its overall activity can be controlled by 
inhibition or activation of its responsible enzymes. Therefore, pathway analysis is combined with FBA to 
eliminate the existence of infeasible flux distribution caused by FBA uncertainty, and also integrate 
metabolic engineering to genetic technology for achieving the synthesis of novel products or redirecting 
metabolite fluxes towards a desired product. Based on the combination of FBA and pathway analysis, the 
optimal mass flux distribution among these elementary pathways for the maximum productivity of a desired 
metabolite can be predicted. Moreover, each elementary pathway is a collection of individual reaction steps. 
The overall reaction of an elementary pathway includes only external metabolites and cofactors. Thus, two 
stoichiometric matrices, A  and U , can be derived from pathway analysis. ),( pjA  represents a MN   
stoichiometric matrix, in terms of N number of reactions Rj , in a total of M elementary pathways 
Pp . ),( epU  is a M×Y stoichiometric matrix in terms of Y external metabolites and cofactors EMe  in 
a total of M elementary pathways Pp . B  is a 1M  flux vector referring to the flux distribution in 
elementary pathways p ( Pp ) detected in the system, the values of which can not be negative. The 
relationship between reaction flux distribution V and pathway flux distribution B  can be expressed as:  
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If VE  is a 1Y  flux vector in terms of Y number of external metabolites e ( EMe ) in a system, the 
overall equations for elementary pathways give rise to the stoichiometry of overall reactions (Eq. (7)).  
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Substituting Eq. (6) into Eq. (5), Eq. (8) is resulted. 
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2.3  Optimisation Approach and Inclusion of Thermodynamic Analysis 
 
An optimisation approach is developed, which combines the metabolic flux analysis and pathway 
identification as illustrated by Eqs. (5)-(8) in section 2.2 and the thermodynamic analysis discussed in Eqs. 
(2)-(4) in section 2.1 (Fig. 3). The optimisation approach is presented as two modules. In module 1, the 
objective is the productivity of an external metabolite (desired product) and is maximised by linear 
programming (LP). In module 2, thermodynamic optimisation (NLP) in terms of minimisation of the total 
Gibbs free energy change of a metabolic system is carried out to predict the optimal cellular conditions. The 
formulations for module 2 are non-linear due to the calculation of formation Gibbs free energy of external 
metabolites and cofactors. The detailed algorithm of the optimisation strategy is presented in Fig. B1 in 
Appendix B, and illustrated in the following sections.  
 
2.3.1  Productivity Maximisation 
 
In addition to the existing approaches 13,5,3 , we have combined the flux balance analysis together with 
pathway analysis (section 2.2; Eqs. (5)-(8)) to achieve the optimal flux distribution among pathway modes, 
 rather than for individual reactions, which satisfies the desired physiological endpoint, eg., the maximum 
productivity of external metabolites. Moreover, an inequality thermodynamic constraint defining the 
negative Gibbs free energy change for individual metabolic pathways is used to ensure the feasibility of flux 
balance analysis (Eq. (9)). The new thermodynamic properties designed for biochemical reactants17  in 
terms of the standard formation Gibbs free energy change ( EMefG  , ) are predicted for external metabolites 
and cofactors in individual metabolic pathways (Eqs. (2), (3)-(4)). Based on these values, the standard 
pathway Gibbs free energy changes ( o PpG  ) are determined using stoichiometric balance among external 
metabolites and cofactors in individual elementary pathways. The constraint for the negative Gibbs free 
energy change of pathways is expressed in Eq. (9).  
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GP  is a 1M  vector of the standard Gibbs free energy changes for elementary  pathways ( o PpG  ), GE  
is a 1Y  vector of the standard formation Gibbs free energy of external metabolites and cofactors 
( EMefG  , ) at specified pH and ionic strength, and M is the number of elementary pathways included in a 
system. 
 
The strategy for a productivity maximisation is depicted in Fig. 4. The productivity of a desired external 
metabolite is defined as the objective function to be maximised for a given set of reacting rates of substrates. 
The decision variable is the pathway flux distribution B . The LP problem formulation can be expressed as 
follows: 
 
Maximise   OBJECT  }{ OBJe         (Productivity Maximisation)          
Subject to Eqs. (6), (8), (9) and 0B  
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reactingr  in Eq. (10) presents the reacting rates of external metabolites ( UPTe ) acting as precursors or 
substrates (sources) in a system and is user specified or a controlling variable. OBJECT  is the property 
vector of the productivity of a desired external metabolite e, which is defined as the objective function to be 
maximised for a given set of substrates.  
 
2.3.2  Gibbs free energy minimisation  
 
From productivity maximisation, the optimal flux distribution of pathways (
opt
B ) and the maximum 
generation of the desired product are achieved. The next step is to determine the minimum total Gibbs free 
energy change of metabolic pathways. Therefore, the optimal flux distribution achieved by the productivity 
maximisation is used as an input to the thermodynamic evaluation (Eq. (11)). The NLP problem formulation 
can be expressed as follows: 
 
Minimise   totG                      (Gibbs free energy change minimisation) 
Subject to:    Eqs. (2)-(4), (9), (10) 
             
opt
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Negative Gibbs free energy change is also used as a constraint in optimisation. totG  is the total Gibbs free 
energy change of the system (Eq. (12)), which is defined as the objective function to be minimised. Since 
T
GP  is presented as a function of cellular pH and ionic strength (Eqs. (2), (3) and (4)), the minimisation of 
Gibbs free energy change results into optimal cellular conditions such as pH and ionic strength I. Since 
 cellular metabolism is a very tightly controlled process, the above two input variables can be optimised 
within very narrow ranges of limits specified, e.g. pH = 6.8-7 and I = 0.28-0.3. 
 
In the context of the overall metabolism engineering design procedure, the proposed methodology (Eqs. 
(1)-(12) and Figs. 3-5) can be integrated with the experimental program and industrial processes. Its 
purpose is to systematically screen and set up the incentives for the promising pathways towards a 
performance target. A priority selection among metabolic elementary pathways can be achieved from flux 
and energy constrained optimisation analysis of a metabolism system. The differences in thermodynamic 
driving forces for the selected pathways provide a basis for experiment measurements. The optimal cellular 
conditions of pH and ionic strength attained by thermodynamic optimisation are valuable for practical 
experiments or industrial processes. In addition to biological insights, this approach can be adopted in the 
construction of engineered metabolism pathways by enzyme controlling or some other gene altering 
technologies. Based on our model, a functional network of elementary metabolic pathways and their 
predicted flux distribution can be established to govern the cellular metabolic system towards achieving an 
objective. 
 
3. Case Study 
 
A case study on the synthesis of pentose phosphate pathways (PPP) and glycolysis of in silico model of 
Escherichia coli metabolism has been used to illustrate the proposed optimisation approach.  
 
3.1  The representation of the metabolic network 
 
The metabolism network under consideration is embedded with the glycolytic pathway and the pentose 
phosphate pathway in the in silico model of E. coli metabolism. This network incorporated 26 metabolites 
 (4 external metabolites, 15 internal metabolites, 7 cofactors) and 19 metabolic reactions (Tables 2-3). An 
overview of the reaction scheme for the model is indicated in Fig. 6. Among the external metabolites, 
glucose-6-phosphate is considered as the only carbon source consumed through the system while producing 
metabolic products. Other external metabolites include carbon dioxide, Ribose 5-phosphate, and pyruvate. 
Pyruvate has been assumed as the objective sink for the productivity maximisation.  
 
Formulation of the pathway analysis in a network has been described previously 23 . Thirteen elementary 
path modes have been derived from computation as shown in Table 4. Fig. 7 describes the pathway mode 3 
as an example to illustrate the reactions involved in this pathway. 
 
Based on the results of flux balance analysis and pathway analysis, a stoichiometry of metabolic reactions is 
presented by a 1915  stoichiometric matrix ),( jiS  (Table 5), and a 1319  stoichiometric matrix A  is 
derived from the stoichiometry of reactions in each pathway (Table 6). A 1113  stoichiometric matrix U  
presenting the stoichiometry of external metabolites and cofactors in each pathway is shown in Table 7.  
 
3.2  Thermodynamic properties of the external metabolites and cofactors 
 
All the biochemical species of the external metabolites and cofactors involved in the metabolism network 
(Fig. 6) as well as their corresponding thermodynamic properties of the standard formation Gibbs free 
energy at 25℃,1 bar and I=0, are illustrated in Table 4. Firstly, the standard formation Gibbs free energy 
of these species, at an initial pH and ionic strength ( 8.6pH , 28.0I ) is calculated using Eq. (2) and (3) 
respectively, based on their hydrogen atom numbers )( HNi  and the charge iz  (Table 8). Next, the 
standard formation Gibbs free energy for all the external metabolites and, like ATP, ADP and inorganic 
phosphate, are calculated using Eq. (4), shown in Table 9. 
 
 3.3  Optimisation Approach 
 
3.3.1  Productivity maximisation 
 
For the productivity maximisation, the objective is to maximise the product flux of pyruvate using the flux 
balance analysis (Eqs. (5)-(10)). The reacting rate of glucose-6-phosphate has been specified to be 
115mmol/gDCWh 24 . Eqs. (6), (9)-(10) are solved using the LP optimisation solver in General Algebraic 
Modeling System (GAMS)/BDMLP on a Pentium® 4CPU, 3 GHz and 512 MB of RAM. The 
computational time is 1.7 seconds. It yields the theoretical maximum productivity rate of pyruvate of 115 
mmol/gDCWh. This is obviously maximised compared to the unoptimised pyruvate rate of 44.3 
mmol/gDCWh, from experiments 24 . The corresponding pathways obtained that are responsible for the 
maximum productivity of pyruvate, are modes 2, 4, 7 and 9 in Fig. 8. To demonstrate the importance of 
Gibbs free energy change as a sufficient constraint to optimisation, two sets of optimal pathway 
distributions derived with and without Gibbs free energy constraint is illustrated in Fig. 9. Their 
corresponding Gibbs free energy changes are summarized in Table 10. The optimal pathway modes derived 
from optimisation without Gibbs free energy constraint are modes 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12, but 
some of them have positive Gibbs free energy changes which oppose their thermodynamic feasibility. 
However, with Gibbs free energy constraint, the corresponding optimal pathways derived are modes 2, 4, 7, 
and 9, all of which have been strictly constrained to ensure the feasibility and direction of the pathways. The 
Gibbs free energy change for this process at the initial conditions is -54696.774 1molkJ . Additionally, the 
results in terms of reaction flux distribution and productivity solely from FBA 5,4,3  are presented in Table 11 
in order to establish the distinction of the combined FBA and pathway analysis, introduced in this work. 
Although the maximum productivity derived from FBA alone is also 115 mmol/gDCWh, which is the same 
as that obtained from the combined FBA and pathway analysis, the feasibility of this reaction flux 
distribution is uncertain. Therefore, pathway analysis is still needed further to distribute these reaction 
 fluxes into different pathways so as to capture the genetic or enzymatic manipulation of cellular activities. 
Based on the reaction flux distribution from FBA alone, a set of pathway distributions with the 
corresponding Gibbs free energy changes is derived as shown in Table 12. The pathways selected from FBA 
alone are 3 and 6, between which the pathway 3 is an infeasible pathway resulting into positive Gibbs free 
energy change of 17539.340 kJ/mol. Thus, we may conclude that only the methodology combining FBA and 
pathway analysis incorporating thermodynamic constraints can ensure the representation of the metabolic 
genotype-phenotype relations and related cellular control activities. 
 
3.3.2  Gibbs free energy minimisation 
 
To predict the optimal reaction conditions, the optimal flux distribution achieved by the productivity 
maximisation in section 3.3.1 is used as an input to thermodynamic optimisation. Using Eqs. (2), (3)-(4), the 
standard formation Gibbs free energy of the external metabolites and cofactors of the system (Fig. 6) as 
functions of pH, ionic strength I is computed. The expression of the standard pathway Gibbs free energy 
changes for pathway modes are derived from the stoichiometry of the overall reaction equations of these 
pathways. The objective function is the minimisation of the total Gibbs free energy for all the pathways 
included (Eq. (13)). The problem is non-linear due to Eqs. (2), (3)-(4). This NLP optimisation problem is 
solved via the NLP optimisation solver in General Algebraic Modeling System (GAMS)/CONOPT on a 
Pentium® 4CPU, 3 GHz and 512 MB of RAM. The computational time is 2.3 seconds. The result of the 
Gibbs free energy minimisation is presented in Table 13. The optimal cellular level reaction conditions 
obtained are 7pH and 3.0I . The corresponding Gibbs free energy change for this process is 
-67608.11 1molkJ , which is significantly minimised compared to the initial value (-54696.774 1molkJ ). 
Fig. 10 shows that the Gibbs free energy changes for pathway 2, 4 and 9, as well as the total Gibbs free 
energy change is obviously minimised after minimisation, although the Gibbs fee energy change of mode 7 
is slightly increased. 
  
4.  Conclusion 
 
A novel optimisation methodology has been presented for the productivity and thermodynamic performance 
of metabolic systems. The theoretical connection between flux balance analysis and pathway analysis is 
well established. Their combined application has been integrated with the thermodynamic constraints on 
Gibbs free energy based driving force in order to predict the maximum productivity of desired products and 
the optimal metabolic flux distribution. Moreover, thermodynamic optimisation in terms of the Gibbs free 
minimisation has been successfully developed for metabolic systems, from which, the best cellular 
conditions are predicted. The heuristic idea of introducing thermodynamic analysis into metabolic 
engineering presents a new way to rationalize metabolic pathway analysis, hence, providing a better control 
mechanism for industrial bioprocesses. The work presented in this paper is an essential step forward in 
establishing cellular pathway level control for productivity maximisation.  
 
  
Appendix A  
 
Glossary 
 
Metabolism: 
The processes occur within living cells or organisms that are necessary for the maintenance of life. In 
metabolism some substances are broken down to yield energy for vital processes while other substances, 
necessary for life, are synthesized. 
 
Metabolites: 
Substances consumed or produced by metabolism, can be external or internal to a cellular system. 
 
External metabolites:  
Metabolites buffered by connection to reservoirs. They can be considered to be sources and sinks (nutrients and 
waste products, stored or excreted products, or precursors for further transformations), exchanged be tween a 
cellular system and its environment. 
 
Internal metabolites:  
Metabolites only participate in reactions of the model, the formation of which are exactly balanced by 
consumption within a cellular system. 
 
Cofactors: 
Substances, such as metallic ions or coenzymes, must be associated with an enzyme for the enzyme to function. 
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Fig. 1  Calculation of the standard formation Gibbs free energy for biochemical reactants 
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Fig. 2  Flux balance analysis 
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Fig. 3  Modules for Optimisation  
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Fig. 4   Module 1: Productivity maximization 
 
 
\
 Gibbs free energy 
change of pathways 
Optimal pathway flux 
distribution 
Gibbs free energy 
change minimization 
 
 
Fig. 5  Module 2: Gibbs free energy minimization 
 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6  Overview of the metabolic network of Glycolysis and PPP in E.coli model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7  Graphical representation of the pathway mode 3 pertaining to the reaction scheme 
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Fig. 8  Graphical representation of the pathway mode 2, 4,7 and 9 
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Fig. 9 Comparison of the optimal pathway flux distribution with and without Gibbs free energy 
constraint 
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Fig. 10 Comparison of the Gibbs free energy change for elementary pathways before and after 
minimisation 
 
 Tables 
 
Table 1  Properties for 4ATP , 3HATP , 22 ATPH  at 25℃, 1 bar, and I = 0 
Species 1/  molkJG of  Charges iz  Hydrogen atom numbers )(HNi  
4ATP  -2573.49 4 12 
3HATP  -2616.87 3 13 
2
2 ATPH  -2643.58 2 14 
 
 
 
Table 2  Metabolic reactions of glycolysis and PPP in E.coli model 
Enzyme Gene Rxn no. Reaction 
Glycolysis(10) 
Phosphoglucose isomerase pgi 1 PFPG 66   
Phosphafructokinase pfkA 2 FDPADPATPPF 6  
Fructose-1,6-bisphosphatase fbp 3 PIPFFDP  6  
Fructose-1,6-bisphophate aldolase fba 4 2313 PTPTFDP   
Triosphosphate isomerase tpiA 5 2313 PTPT   
Glyceraldehyde-3-phosphate dehydrogenase gapA 6 PDGNADHNADPIPT 1313   
Phosphoglycerate kinase pgk 7 PGATPADPPDG 313   
Phosphoglycerate mutes gpmA 8 PGPG 23   
Enolase eno 9 PEPPG 2  
Pyruvate kinase pyk 10 PYRATPADPPEP   
Pentose phosphate pathway (PPP)(9) 
Glucose-6-phosphate dehydrogenase zwf 11 PGLDNADPHNADPPG 66   
6-Phophogluconolactonse pgl 12 PGCDPGLD 66   
6-Phosphogluconate dehydrogenase gnd 13 PRLCONADPHNADPPGCD 56 2   
Ribose-5-phosphate isomerase rpiA 14 PRPRL 55   
Ribulose phosphate 3-epimerase rpe 15 PXPRL 55   
Transketolase 1 tktI 16 PSPTPRPX 71355   
Transaldolase tal 17 PFPEPSPT 64713   
Transketolase 2 TktII 18 13645 PTPFPEPX   
5-Phosphoribosyl-1-pyrophosphate synthetase Prs 19 PexRPR 55   
 
 
 
  
 
Table 3  Metabolites of glycolysis and PPP in E.coli model 
Abbreviation Compound 
External metabolites(4) 
PG6  Glucose 6-phosphate 
PYR Pyruvate 
2CO  Carbon dioxide 
PexR5  Ribose 5-phosphate (external) 
Internal metabolites(15)  
PF6  Fructose 6-phosphate 
FDP  Fructose 1,6-diphosphate 
13PT  Glyceraldehyde-3-phosphate 
23PT  Dihydroxyacetone phosphate 
PDG13  1,3-P-d glycerate 
PG3  3-P-d glycerate 
PG2  2-P-d glycerate 
PEP  Phosphoenolpyruvate 
PGLD6  d-6-Phosphogluconate 
PGCD6  d-6-Phosphoglucono- -lactone 
PRL5  d-Ribulose 5-phosphate 
PR5  Ribose 5-phosphate 
PX 5  Xylulose-5-phosphate 
PS7  d-Sedoheptulose-7-P 
PE4  Erythrose 4-phosphate 
Cofactors(7)  
ATP  Adenosine triphosphate 
ADP  Adenosine diphosphate 
NAD  
NADH  
Nicotinamide adenine dinucleotide 
NADP  
NADPH  
Nicotinamide adenine dinucleotide phosphate 
PI  Phosphate 
 
 
 
 
 
  
 
Table 4  Elementary path modes of the combined glycolysis and PPP system 
 
Mode Overall equation Steps 
1 PyrNADHATP
NADPiADPPG
223
2236

  pgi, pfkA, fba, tpiA, 2gapA, 2pgk, 2gpmA, 2eno, 
2pyk 
2 PyrCONADHPNADHATP
NADPNADPiADPPG


2362
626  -2pgi, gapA, 3zwf, 3pgl, 3gnd, rpiA, 2rpe, tktI, tal, 
tktII, pgk, gpmA, eno, pyk, 
3 PyrCONADHPNADHATP
NADPNADPiADPPG
53658
655863
2 
  2pfkA, 2fba, 2tpiA, 5gapA, 3zwf, 3pgl, 3gnd, rpiA, 
2rpe, tktI, tal, tktII, 5pgk, 5gpmA, 5eno, pyk  
4 PexRCONADPHNADPPG 5226 2   zwf, pgl, gnd, rpiA, Prs 
5 PexRADPATPPG 5665   5pgi, pfkA, fba, tpiA, 4rpiA, -4rpe, -2tktI, -2tal, -2tktII, 6Prs 
6 2612126 COPiNADPHNADPPG   -5pgi, -fba, -tpiA, 6zwf, 6pgl, 6gnd, 2rpiA, 4rpe, 2tktI, 2tal, 2tktII, fbp 
7 PiADPATP   pfk, fbp 
8 PyrPGNADHATP
PexRNADPiADP


622
532  -2pgi, gapA, -2rpiA, 2rpe, tktI, tal, tktII, pgk, gpmA, 
eno, pyk, -3Prs 
9 PyrNADHPNADHATPCO
PexRNADPNADPiADP


422
542
2
 -2pgi, gapA, 2zwf, 2pgl, 2gnd, 2rpe, tktI, tal, tktII, 
pgk, gpmA, eno, pyk, -Prs 
10 PyrNADHATP
PexRNADPiADP
558
53558

  2pfkA, 2fba, 2tpiA, 5gapA, -2rpiA, 2rpe, tktI, tal, 
tktII, 5pgk, 5gpmA, 5eno, 5pyk, -3Prs 
11 PyrNADHPNADHATPCO
PexRPGNADPNADPiADP
54582
5624558
2 
  2pfkA, 2fba, 2tpiA, 5gapA, 2zwf, 2pgl, 2gnd, 2rpe, 
tktI, tal, tktII, 5pgk, 5gpmA, 5eno, 5pyk, -Prs 
12 PiPGPexR  6556  -5pgi, fbp, -fba, -tpiA, -4rpiA, 4rpe, 2tktI, 2tal, 2tktII,-6 Prs 
13 PiPGNADPHCOPexRNADP  684528 2  -5pgi, fbp, -fba, -tpiA, 4zwf, 4pgl, 4gnd, 4rpe, 2tktI, 2tal, 2tktII, -Prs 
 
 
 
 
 
 
 
 
 
 Table 5   Stoichiometric matrix ),( jiS  in terms of internal metabolites IMi  in reactions Rj  
internal metabolites 
reactions 
PF6  FDP  13PT  23PT  PDG13  PG3 PG2 PEP PGLD6 PGCD6 PRL5  PR5  PX 5  PS7 PE4
1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
    2 -1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
3 1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 
4 0 -1 1 1 0 0 0 0 0 0 0 0 0 0 0 
5 0 0 -1 1 0 0 0 0 0 0 0 0 0 0 0 
6 0 0 -1 0 1 0 0 0 0 0 0 0 0 0 0 
7 0 0 0 0 -1 1 0 0 0 0 0 0 0 0 0 
8 0 0 0 0 0 -1 1 0 0 0 0 0 0 0 0 
9 0 0 0 0 0 0 -1 1 0 0 0 0 0 0 0 
10 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 
11 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
12 0 0 0 0 0 0 0 0 -1 1 0 0 0 0 0 
13 0 0 0 0 0 0 0 0 0 -1 1 0 0 0 0 
14 0 0 0 0 0 0 0 0 0 0 -1 1 0 0 0 
15 0 0 0 0 0 0 0 0 0 0 -1 0 1 0 0 
16 0 0 1 0 0 0 0 0 0 0 0 -1 -1 1 0 
17 1 0 -1 0 0 0 0 0 0 0 0 0 0 -1 1 
18 1 0 1 0 0 0 0 0 0 0 0 0 -1 0 -1 
19 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 
 
 
 
Table 6   Stoichiometric matrix ),( pjA  in terms of reactions Rj  in elementary pathways Pp  
 
Reactions   
Elementary pathways 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
1 1 1 0 1 1 2 2 2 2 2 0 0 0 0 0 0 0 0 0
2 -2 0 0 0 0 1 1 1 1 1 3 3 3 1 2 1 1 1 0
3 0 2 0 2 2 5 5 5 5 5 3 3 3 1 2 1 1 1 0
4 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 1
5 5 1 0 1 1 0 0 0 0 0 0 0 0 4 -4 -2 -2 -2 6
6 -5 0 1 -1 -1 0 0 0 0 0 6 6 6 2 4 2 2 2 0
7 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
8 -2 0 0 0 0 1 1 1 1 1 0 0 0 -2 2 1 1 1 -3
9 -2 0 0 0 0 1 1 1 1 1 2 2 2 0 2 1 1 1 -1
10 0 2 0 2 2 5 5 5 5 5 0 0 0 -2 2 1 1 1 -3
11 0 2 0 2 2 5 5 5 5 5 2 2 2 0 2 1 1 1 -1
12 -5 0 1 -1 -1 0 0 0 0 0 0 0 0 -4 4 2 2 2 -6
13 -5 0 1 -1 -1 0 0 0 0 0 4 4 4 0 4 2 2 2 -1
 
 
  
Table 7  Stoichiometric matrix ),( epU  in terms of external metabolites and cofactors EMe  in 
elementary pathways Pp  
Elementary pathways 
External metabolites and cofactors 
1 2 3 4 5 6 7 8 9 10 11 12 13
ATP  3 2 8 0 -1 0 -1 2 2 8 8 0 0 
ADP  -3 -2 -8 0 1 0 1 -2 -2 -8 -8 0 0 
PG6  -1 -1 -3 -1 -5 -1 0 2 0 0 -2 5 1 
PYR 2 1 5 0 0 0 0 1 1 5 5 0 0 
PexR5  0 0 0 1 6 0 0 -3 -1 -3 -1 -6 -2 
2CO  0 3 3 1 0 6 0 0 2 0 2 0 4 
NAD  -2 -1 -5 0 0 0 0 -1 -1 -5 -5 0 0 
NADH  2 1 5 0 0 0 0 1 1 5 5 0 0 
NADP  0 -6 -6 -2 0 -12 0 0 -4 0 -4 0 -8 
NADPH  0 6 6 2 0 12 0 0 4 0 4 0 8 
PI  -2 -1 -5 0 0 1 1 -1 -1 -5 -5 1 1 
 
 
Table 8  Standard formation Gibbs free energy, charges and hydrogen atom numbers for species 
Species 1/  molkJG of  Charges iz  Hydrogen atom numbers )(HNi  
26PG  -1763.94 2 11 
PYR  -472.27 1 3 
25PR  -1605.34 2 9 
NAD  0 1 26 
2NADH  22.65 2 26 
3NADP  0 3 25 
4NADPH  25.99 4 25 
2
4HPO  -1095.1 2 1 

42 POH  -1137.3 1 2 
4ATP  -2573.49 4 12 
3HATP  -2616.87 3 13 
2
2 ATPH  -2643.58 2 14 
3ADP  -1711.55 3 12 
2HADP  -1752.53 2 13 
ADPH 2  -1777.42 1 14 
 
 
 
 
  
 
Table 9  Standard formation Gibbs free energy for external metabolites and cofactors at 8.6pH , 
28.0I  
 
External metabolites and cofactors 1/  molkJG of  
PG6  -1331.29 
PYR  -354.198 
PexR5  -1251.96 
NAD  1029.701 
NADH  1049.842 
NADP  983.3745 
NADPH  1003.511 
PI  -1230.57 
ATP  -2376.47 
ADP  -1508.15 
 
 
 
 
 
 
 
Table 10  Comparison of optimal pathway flux distribution and their corresponding Gibbs free energy 
changes 
 
without G  constraint with G  constraint Elementary 
Modes Pathway flux distribution B(p)
(mmol/gDCWh) 
G  
molkJ /  
Pathway flux distribution B(p) 
(mmol/gDCWh) 
G  
molkJ /  
1 5.62 3390.493 0 0 
2 5.62 -2495.21 95.746 -42509.4 
3 10 7625.8 0 0 
4 5.62 -1375.01 19.254 -4710.65 
5 7.976 185.676 0 0 
6 45.785 -85583.7 0 0 
7 5.62 -2124.45 9.627 -3639.07 
8 1.808 524.388 0 0 
9 1.808 -360.417 19.254 -3837.68 
10 1.808 2706.131 0 0 
11 7.096 7147.792 0 0 
12 5.62 -2255.29 0 0 
13 0 0 0 0 
 
 
 
 Table 11  Reaction flux distribution derived from FBA alone 
 
Reaction Reaction flux distribution V(j)(mmol/gDCWh) 
1 -230 
2 46 
3 46 
4 0 
5 0 
6 115 
7 115 
8 115 
9 115 
10 115 
11 345 
12 345 
13 345 
14 115 
15 230 
16 115 
17 115 
18 115 
19 0 
 
 
Table 12  Pathway analysis based on the result of reaction flux distribution derived from FBA alone 
Pathway Reaction flux distribution B(p)(mmol/gDCWh) 
G  
molkJ /  
1 0 0 
2 0 0 
3 23 17539.34 
4 0 0 
5 0 0 
6 46 -85985.5 
7 0 0 
8 0 0 
9 0 0 
10 0 0 
11 0 0 
12 0 0 
13 0 0 
 
 
  
Table 13  Standard formation Gibbs free energy at optimal condition 
External metabolites and cofactors 1/  molkJG optf  
PG6  -1318.634 
PYR  -350.745 
PexR5  -1241.617 
NAD  1059.736 
NADH  1079.833 
NADP  1012.137 
NADPH  1032.171 
PI  -1228.872 
ATP  -2361.616 
ADP  -1493.225 
1/  molkJGopttot  -5577.197 
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Nomenclature 
 
 Symbol                Name                                                     Unit 
oc     standard state concentration (1M)                                      lmol /  
G             extensive Gibbs free energy of a system                                 kJ  
G              extensive transformed Gibbs free energy of a system                      kJ  
i
o
fG           standard formation Gibbs free energy of species i at specified T, P, and I       molkJ /  
)(reactG of      standard formation Gibbs free energy of reactant i at specified T, P, pH and I   molkJ /  
EMefG  ,        standard formation Gibbs free energy of external metabolites and  
cofactors e at specified T, P, pH and I         molkJ /  
o
PpG           standard Gibbs free energy change of pathway p at specified T, P, pH and I    molkJ /  
I               ionic strength                                                      lmol /  
)(HNi           number of H atoms in species i                                    dimensionless 
pH              )/]log([ ocH                                                  dimensionless 
P               pressure                                                         bar 
R               gas constant ( 1131451.8  molJK )                                    11  molJK  
T               temperature                                                       K 
iz               charge of ion i                                                 dimensionless 
o
i              standard chemical potential of species i at specified T, P, and I             molkJ /  
ereacting
r            reacting rate of external metabolites e ( UPTe )                     gDCWhmmol /  
Sets 
IM = {1, 2…, X / internal metabolites} 
EM = {1, 2…, Y / external metabolites and cofactors} 
R = {1, 2…, N / reactions of the metabolic system} 
P = {1, 2…, M / pathways of the metabolic system} 
OBJ = { e / objective product under optimisation, EMOBJ  } 
UPT = { e / external metabolite uptake from external metabolite measurement, EMUPT  } 
Variables & Parameters 
V              property vector of metabolic flux for individual reactions Rjj ,  
B               property vector of metabolic flux for elementary pathways Ppp ,  
optB            property vector of optimal metabolic flux for elementary pathways Ppp ,  
S                stoichiometric matrix for internal metabolite i ( IMi ) in reaction j ( Rj ) 
A               stoichiometric matrix for reaction j ( Rj ) in elementary pathway p ( Pp ) 
U               stoichiometric matrix for external metabolites e ( EMe ) in pathway p ( Pp ) 
VE              property vector of metabolic flux for external metabolites and cofactors EMee ,  
GE              property vector of  standard formation Gibbs free energy of external metabolites and  
cofactors e ( EMe ) at specified pH and ionic strength 
GP              property vector of standard Gibbs free energy changes for elementary pathways p ( Pp ) 
totG             total Gibbs free energy change of the system 
reactingr            property vector of the reacting rates of given steady external metabolites e  ( UPTe )   
OBJECT         property vector of the productivity of desired external metabolite e  ( OBJe ) 
